Filing Details

Accession Number:
0001206386-12-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-28 16:26:37
Reporting Period:
2012-02-27
Filing Date:
2012-02-28
Accepted Time:
2012-02-28 16:26:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206386 M Richard Marsh 320 Wakara Way
Salt Lake City UT 84108
E.v.p., General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-27 43,981 $5.89 57,986 No 4 M Direct
Common Stock Disposition 2012-02-27 43,981 $23.99 14,005 No 4 S Direct
Common Stock Acquisiton 2012-02-27 9,040 $7.82 23,045 No 4 M Direct
Common Stock Disposition 2012-02-27 9,040 $23.99 14,005 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-27 43,981 $0.00 43,981 $5.89
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-02-27 9,040 $0.00 9,040 $7.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-09-08 No 4 M Direct
60,960 2015-02-17 No 4 M Direct
Footnotes
  1. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.